drugset / Trial / NCT00616460
ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the safety/efficacy of Bivallirudin Vs unfractionated heparin (UFH) on top of dual antiplatelet therapy in patients with high tendency for bleeding during urgent and elective PCI.
Timeline
- Start
- 2008-02
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bivalirudin | Peptide | 1.75 mg/kg | — |